Please login to the form below

Not currently logged in

UCB CEO elected to the Ministerial Industry Strategy Group

Jean-Christophe Tellier assumed the role of CEO on January 1
Jean-Christophe Tellier

UCB's new CEO Jean-Christophe Tellier has been elected to join the Ministerial Industry Strategy Group (MISG).

Tellier was elected by member of the European Medicines Group (EMG) and will act as group representative for the European pharma companies.

Commenting on the election, Tellier said: “The UK life sciences industry is one of the most successful at a global level and it is an important contributor to the country's economic prosperity.

“Therefore, I am pleased to be sharing some of UCB's experience as an inward R&D inward investor with the MISG, in an effort to shape a positive climate that incentivises innovation for the improvement of patient care.”

Tellier joined UCB in 2011 as an executive VP after serving as president of Ipsen, North America, and CEO of Novartis pharma France. He has 25 years of experience in the industry, aided by a medical background as a rheumatologist.

Tellier was named as UCB's next CEO early last year, but did not assume the role until January 1 of this year.

25th February 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge